Prostatype Genomics study shows low-risk group records zero prostate cancer deaths over 20 years
A 20-year follow-up study of 137 prostate cancer patients presented by Prostatype Genomics showed that patients identified as low-risk by the Prostatype test recorded zero prostate cancer deaths. The study, which followed patients from Uppsala University Hospital, indicated Prostatype outperformed the NCCN risk framewo